Dyslipidemias
📧 Sign up to get email alerts when something new happens for Dyslipidemias.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2022-05-27FDA Approved: FENOFIBRATE — Supplemental Application (Cipla USA Inc.)
FDA notice of a supplemental application for fenofibrate submitted by Cipla USA Inc., likely to update labeling or usage indications.